AI Science Tracker
EN

Continuous and early prediction of future moderate and severe Acute Kidney Injury in critically ill patients: Development and multi-centric, multi-national external validation of a machine-learning model.

Affiliation not stated in the reviewed material · 25 Jul 2023 · medicine

Discovery

Continuous and early prediction of future moderate and severe Acute Kidney Injury in critically ill patients: Development and multi-centric, multi-national external validation of a machine-learning model.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: An hourly machine-learning model predicted future stage 2/3 acute kidney injury across 16,760 ICU patients from 145 centers in three countries, with multicenter external validation reported.

Technology: An hourly machine-learning model predicted future stage 2/3 acute kidney injury across 16,760 ICU patients from 145 centers in three countries, with multicenter external validation reported.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
An hourly machine-learning model predicted future stage 2/3 acute kidney injury across 16,760 ICU patients from 145 centers in three countries, with multicenter external validation reported.
Limitation / still unknown
Multicenter external validation supports prediction across the reported ICU data; prospective clinical deployment and improved AKI outcomes were not demonstrated.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1371/journal.pone.0287398

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.